Results 101 to 110 of about 8,420 (208)

Development of Buccal Adhesive Tablets of Olmesartan Medoxomil. [PDF]

open access: yes, 2014
The most preferred route of drug administration for systemic delivery of drugs is oral route. More than 50% of drug delivery systems available in the market are oral drug delivery systems.
Rajeshkumar, J
core  

LC-MS method for determination of olmesartan in human plasma

open access: yes, 2015
Olmesartan belongs to a class of drugs called angiotensin II receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily and is used to treat high blood pressure (hypertension).
Edyta Piórkowska   +4 more
core   +1 more source

Reversal of vascular hypertrophy in hypertensive patients through blockade of angiotensin II receptors

open access: yesКардиоваскулярная терапия и профилактика, 2010
Aim. May blockade of the angiotensin II type 1 receptor (AT1) with an angiotensin receptor blocker reverse vascular pathology independent of blood pressure (BP) lowering. Material and methods.
R. D. Smith   +4 more
doaj  

Rapid and selective UV Spectrophotometric method for the analysis of Olmesartan medoxomil in bulk and dosage form. [PDF]

open access: yes, 2012
A new UV spectrophotometric method was developed for quantitative evalution of Olmesartan medoxomil preparations. The UV detector was set at 256nm. Beers law is obeyed in the concentration range of 2.0 -14.0 øg/ml.
D. Gowrishankar   +2 more
core   +2 more sources

Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil

open access: yesVascular Health and Risk Management, 2011
R Preston MasonCardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, and Elucida Research, Beverly, MA, USAAbstract: Cardiovascular (CV) disease is a major factor in mortality rates around the world and ...
Mason
doaj  

Environmentally sustainable UPLC method for estimation of olmesartan medoxomil and apigenin: Stat-Ease optimization, pharmaceutical application and green assessment

open access: yesOpen Chemistry
An effective treatment protocol for hypertension can significantly modify the risk of cardiovascular diseases and reduce the incidence of death. Herein, a novel combination of olmesartan medoxomil and bioactive apigenin offers enhanced therapeutic ...
Elzayat Ehab M.   +3 more
doaj   +1 more source

Simultaneous Analytical Method Development and Validation of Rosuvastatin and Olmesartan Medoxomil in Combined Tablet Dosage form by RP-HPLC

open access: yes, 2021
A RP-HPLC method for Rosuvastatin and Olmesartan medoxomil was developed and Validated in tablet dosage form as pre ICH Guide lines UV visible Detector and Column C18(150 × 4.6mm)5μ injection of 20μl is injected and eluted with the mobile phase of ...
Babu, R
core  

Stability of Olmesartan Medoxomil Extemporaneous Suspensions. [PDF]

open access: yesJ Pharm Technol, 2022
Bhattarai P   +3 more
europepmc   +1 more source

Medication of the Month. Olmesartan Medoxomil Hydroclorothiazide (Olmetec Plus or Belsar Plus [PDF]

open access: yes, 2007
peer reviewedThe therapeutic control of hypertension is still a global challenge and frequently requires combination therapy. Olmesartan medoxomil hydrochlorothiazide (Olmetec plus, Belsar plus) is a fixed-dose combination of olmesartan 20 mg and ...
Lancellotti, Patrizio
core   +1 more source

Olmesartan medoxomil for the treatment of hypertension in children and adolescents

open access: yesVascular Health and Risk Management, 2011
Giuliano Tocci1, Massimo Volpe1,21Chair and Division of Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine, University of Rome “Sapienza”, Sant’Andrea Hospital, Rome; 2IRCCS Neuromed, Pozzilli, ItalyAbstract:
Volpe M, Tocci G
doaj  

Home - About - Disclaimer - Privacy